Defining right ventricular dysfunction by echocardiography in normotensive patients with pulmonary embolism.


Journal

Polish archives of internal medicine
ISSN: 1897-9483
Titre abrégé: Pol Arch Intern Med
Pays: Poland
ID NLM: 101700960

Informations de publication

Date de publication:
30 09 2020
Historique:
pubmed: 25 6 2020
medline: 28 4 2021
entrez: 25 6 2020
Statut: ppublish

Résumé

Although the prognostic value of various echocardiographic parameters of right ventricular dysfunction (RVD) was reported in normotensive patients with acute pulmonary embolism (PE), there is no generally accepted definition of RVD. The aim of the study was to compare echocardiographic parameters for the prediction of an adverse 30‑day outcome and create an optimal definition of RVD.                                     Patients and methods: Echocardiographic parameters including the right ventricular to left ventricular diameter ratio (RV to LV ratio) and tricuspid annular plane systolic excursion (TAPSE) to predict PE‑related mortality, hemodynamic collapse, or rescue thrombolysis within the first 30 days were directly compared in 490 normotensive patients with PE. An adverse outcome (AO) was present in 31 patients (6.3%); 8 of them (1.6%) died due to PE. Systolic blood pressure, RV to LV ratio, and TAPSE were independent predictors of AO. The receiver operator characteristic yielded an area under the curve of 0.737 (0.654-0.819; P <0.001) for the RV to LV ratio and 0.75 (0.672-0.828; P <0.001) for TAPSE with regard to an AO. The hazard ratio for AO was 2.5 for the RV to LV ratio of more than 1 (95% CI, 1.2-5.7; P <0.03) and 3.8 for TAPSE of less than 16 mm (95% CI, 1.74-8.11; P = 0.001). A combined RVD criterion (TAPSE <16 mm and RV to LV ratio >1) was present in 60 patients (12%), and showed a positive predictive value of 23.3% with a high negative predictive value of 95.6% regarding an AO (HR, 6.5; 95% CI, 3.2-13.3; P <0.001). Defining RVD on echocardiography by the RV to LV ratio of more than 1 combined with TAPSE of less than 16 mm identified patients with an increased risk of 30‑day PE‑related mortality, hemodynamic collapse, or rescue thrombolysis, while patients without this sign had a very good 30‑day prognosis.

Identifiants

pubmed: 32579314
doi: 10.20452/pamw.15459
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-747

Auteurs

Piotr Pruszczyk (P)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland

Katarzyna Kurnicka (K)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland. kkurnicka@yahoo.pl

Michał Ciurzyński (M)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland

Lukas Hobohm (L)

Center for Thrombosis and Hemostasis and Center for Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

Aaron Thielmann (A)

Clinic of Cardiology and Pneumology, University Medical Center Goettingen, Goettingen, Germany

Bożena Sobkowicz (B)

Department of Cardiology, Medical University in Bialystok, Białystok, Poland

Emilia Sawicka (E)

Department of Cardiology, Medical University in Bialystok, Białystok, Poland

Maciej Kostrubiec (M)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland

Katarzyna Ptaszyńska-Kopczyńska (K)

Department of Cardiology, Medical University in Bialystok, Białystok, Poland

Olga Dzikowska-Diduch (O)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland

Barbara Lichodziejewska (B)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland

Mareike Lankeit (M)

Center for Thrombosis and Hemostasis and Center for Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Clinic of Cardiology and Pneumology, University Medical Center Goettingen, Goettingen, Germany; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité – University Medicine, Berlin, Germany

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH